“The stem cells were unable to self-renew, which resulted in long-term and irreversible impairment of tumour growth. In other words, the cancer was permanently shut down.”
Scientists and surgeons at Princess Margaret Cancer Centre have discovered a promising new approach to treating colorectal cancer by disarming the gene that drives self-renewal in stem cells that are the root cause of disease, resistance to treatment and relapse. Colorectal cancer is the third leading cause of cancer-related death in the Western world.
“This is the first step toward clinically applying the principles of cancer stem cell biology to control cancer growth and advance the development of durable cures,” says principal investigator Dr. John Dick about the findings published online today in Nature Medicine.
He talks about the research in this video.
Dr. Dick pioneered the cancer stem cell field by first identifying leukemia stem cells (1994) and colon cancer stem cells (2007). He is also renowned for isolating a human blood stem cell in its purest form – as a single stem cell capable of regenerating the entire blood system – paving the way for clinical use (2011). Dr. Dick holds a Canada Research Chair in Stem Cell Biology and is a Senior Scientist at University Health Network’s Princess Margaret Cancer Centre and McEwen Centre for Regenerative Medicine. He is also a Professor in the Department of Molecular Genetics, University of Toronto, and Director of the Cancer Stem Cell Program at the Ontario Institute for Cancer Research.
In pre-clinical experiments, the research team replicated human colon cancer in mice to determine if specifically targeting the stem cells was clinically relevant. First, the researchers identified that the gene BMI-1, already implicated in maintaining stem cells in other cancers, is the pivotal regulator of colon cancer stem cells and drives the cycle of self-renewal, proliferation and cell survival. Next, the team used an existing small-molecule inhibitor to successfully block BMI-1, thus demonstrating the clinical relevance of this approach.
Lead author Dr. Antonija Kreso writes: “Inhibiting a recognized regulator of self-renewal is an effective approach to control tumor growth, providing strong evidence for the clinical relevance of self-renewal as a biological process for therapeutic targeting.”
Dr. Dick explains: “When we blocked the BMI-1 pathway, the stem cells were unable to self-renew, which resulted in long-term and irreversible impairment of tumour growth. In other words, the cancer was permanently shut down.”
The Latest Google Headlines on: Colon cancer
The Latest Bing News on: Colon cancer
- Mayo Clinic Minute: Symptoms of colorectal canceron June 5, 2020 at 6:35 am
Colorectal cancer refers to a cancer that begins to form in the colon or the rectum. It's the second most common cause of cancer death in the U.S., behind lung cancer.
- Never Too Young Survey Report Shows Young-Onset Colorectal Cancer Continues to be Overlooked in Exam Roomson June 4, 2020 at 5:41 pm
The Never Too Young Survey Report shares the self-reported medical, psychosocial, and quality of life experiences of this often-overlooked population to better understand their challenges and needs.
- Nilofer Azad, MD, on Early-Onset Colorectal Canceron June 4, 2020 at 8:50 am
In a recent review, Nilofer Azad, MD, of Johns Hopkins Sidney Kimmel Comprehensive Cancer Center in Baltimore, and colleagues discussed the epidemiology, prevention, diagnosis, management, and ...
- New guidelines improve outcomes in colon cancer patientson June 3, 2020 at 8:57 am
A new University of Kentucky Markey Cancer Center study finds that many Kentucky patients with colon cancer are not receiving the recommended standard of care therapy for their disease.
- Does Oral Bacteria Affect Colon Cancer?on June 2, 2020 at 5:58 am
The colon is a part of the digestive tract whose function is the absorption of water and nutrients from food. Colon cancer is a leading cause of mortality.
- 2020 Global Colorectal Cancer Clinical Trial Pipeline Highlights - ResearchAndMarkets.comon June 2, 2020 at 4:16 am
The "Global Colorectal Cancer Clinical Trial Pipeline Highlights - 2020" report has been added to ResearchAndMarkets.com's offering.
- Blood Test Detects Colon Cancer in Single-Center Studyon June 1, 2020 at 11:31 am
A blood test detected all cases of colorectal cancer in a study of patients undergoing elective colonoscopy, and identified the majority of advanced adenomas.
- Upfront Pembrolizumab Doubles PFS in MSI-H/dMMR Metastatic Colorectal Canceron May 31, 2020 at 10:23 am
Pembrolizumab outperformed chemotherapy in patients with microsatellite-instability high/mismatch repair-deficient metastatic colorectal cancer in the KEYNOTE-177 study.
- Former UW men's hockey defenseman Rob Andringa, who has battled colon cancer since 2017, passes away at age 51on May 29, 2020 at 8:55 pm
Rob Andringa helped UW win an NCAA men's hockey title in 1990 and was the team's color analyst when the Badgers won another title in 2006.
- Colorectal cancer is associated with increased circulating lipopolysaccharide, inflammation and hypercoagulabilityon May 29, 2020 at 2:18 am
Gut dysbiosis contributes to the development of a dysfunctional gut barrier, facilitating the translocation of bacteria and inflammagens, and is implicated in colorectal cancer (CRC) pathogenesis.
The Latest Google Headlines on: Therapeutic stem cells
The Latest Bing News on: Therapeutic stem cells
- Molecular landscape of the hematopoietic stem cell cradleon June 5, 2020 at 7:51 am
Researchers from the group of Catherine Robin at the Hubrecht Institute have characterized the molecular landscape of the aorta that supports the generation of the first hematopoietic stem cells (HSCs ...
- N-3 polyunsaturated fatty acids promote astrocyte differentiation and neurotrophin production independent of cAMP in patient-derived neural stem cellson June 5, 2020 at 2:44 am
Evidence from epidemiological and laboratory studies, as well as randomized placebo-controlled trials, suggests supplementation with n-3 polyunsaturated fatty acids (PUFAs) may be efficacious for ...
- Vitro Biopharma Signs MOU with GIOSTAR for COVID-19 IND Using AlloRx Stem Cellson June 2, 2020 at 10:20 am
GOLDEN, CO / ACCESSWIRE / June 2, 2020 / Vitro Diagnostics, Inc. (OTC PINK:VODG), dba Vitro entered into an exclusive Memorandum of Understanding (MOU) with Global Institute of Stem Cell Therapy and ...
- Study resolves contradictions surrounding p53 gene's role in pluripotent stem cell differentiationon June 1, 2020 at 6:09 pm
The gene p53 is extremely important in cell biology and, hence, the world of cell replacement therapy. Its role is to regulate the cell cycle and halt the formation of tumors, leading to its nickname ...
- Longeveron Announces Japanese Approval of Clinical Trial for Treatment of Aging Frailty With Longeveron’s Stem Cellson June 1, 2020 at 6:00 am
Longeveron LLC announced today that Japan’s Pharmaceutical and Medical Devices Agency (PMDA) (the Japanese agency akin to the United States’ Food & Drug Administration) approved a Clinical Trial ...
- Improving the safety of human pluripotent stem cell therapies using genome-edited orthogonal safeguardson June 1, 2020 at 2:19 am
Human pluripotent stem cell derived therapies can have serious safety risks. Here the authors design two drug inducible genetic safeguards to deplete undifferentiated hPSCs and hPSC-derived cell types ...
- Cleveland Clinic researchers studying if stem cells could help treat ARDS in coronavirus patientson May 28, 2020 at 5:15 am
The Cleveland Clinic is among 15 health systems across the U.S. participating in a clinical trial that will study whether mesenchymal stromal cells could help treat coronavirus patients with acute ...
- CAR-T Cell Therapy Shows Promise against Glioblastoma in Miceon May 28, 2020 at 5:00 am
Study results have led to establishment of brain cancer immunotherapy company, Empirica Therapeutics, which aims to start clinical trials of CD133-specific CAR-T cell therapy by 2022. The same ...
- Stem Cell Therapy Market Trends 2019 Global Industry Share, Growth, Demand, By Type, Top Players, Opportunities and Forecast to 2025on May 27, 2020 at 11:26 pm
Selbyville, Delaware, Global Stem Cell Therapy Market Report added at Market Study Report LLC offers industry size, share, growth, trends and forecast analysis up to 2025. Stem Cell Therapy Market ...
- Gene therapy appears to reduce sickle cell disease-related complicationson May 26, 2020 at 6:58 am
LentiGlobin gene therapy led to reductions in sickle cell disease-related complications and hemolysis, according to results of a phase 1/phase 2 trial presented at the virtual American Society of Gene ...